E-LIB Suche - Ergebnisse für: Komatsu, Yoshito

1

CA125 Kinetics as a Potential Biomarker for Peritoneal Meta..:

Ueda, Akira ; Yuki, Satoshi ; Ando, Takayuki...
Cancers. 16 (2024) 5 - p. 871 , 2024

Link: https://doi.org/10.3390/..

2

Clinical features associated with NeoRAS wild-type metastat..:

Osumi, Hiroki ; Shinozaki, Eiji ; Nakamura, Yoshiaki...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Qu..:

Hashimoto, Tadayoshi ; Nakamura, Yoshiaki ; Fujisawa, Takao...
Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

4

Phase II trial of niraparib forBRCA-mutated biliary tract, ..:

Kawamoto, Yasuyuki ; Morizane, Chigusa ; Komatsu, Yoshito...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

5

Baseline ctDNA gene alterations as a biomarker of survival ..:

Shitara, Kohei ; Muro, Kei ; Watanabe, Jun...
Nature Medicine. 30 (2024) 3 - p. 730-739 , 2024

Link: https://doi.org/10.1038/..

6

English version of Japanese Clinical Practice Guidelines 20..:

Hirota, Seiichi ; Tateishi, Ukihide ; Nakamoto, Yuji...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 647-680 , 2024

Link: https://doi.org/10.1007/..

7

QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFO..:

Bando, Hideaki ; Kotani, Daisuke ; Satake, Hironaga...
Med. , 2024

Link: https://doi.org/10.1016/..

8

Evaluation of the risk factors for the failure of a single ..:

Watanabe, Takuya ; Saito, Yoshitaka ; Takekuma, Yoh...
Int. Journal of Clinical Pharmacology and Therapeutics. 62 (2024) 5 - p. 213-221 , 2024

Link: https://doi.org/10.5414/..

9

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuxi..:

Kotani, Daisuke ; Takashima, Atsuo ; Kato, Takeshi...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 174-182.e6 , 2024

Link: https://doi.org/10.1016/..

10

Three-year outcomes of preoperative chemoradiotherapy plus ..:

Tsukada, Yuichiro ; Bando, Hideaki ; Inamori, Koji...
British Journal of Cancer. 131 (2024) 2 - p. 283-289 , 2024

Link: https://doi.org/10.1038/..

11

Impact of preexisting proteinuria on the development of reg..:

Saito, Yoshitaka ; Takekuma, Yoh ; Komatsu, Yoshito.
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

12

Doublet chemotherapy, triplet chemotherapy, or doublet chem..:

Kato, Ken ; Machida, Ryunosuke ; Ito, Yoshinori...
The Lancet. 404 (2024) 10447 - p. 55-66 , 2024

Link: https://doi.org/10.1016/..

13

Large-scale, prospective observational study of regorafenib..:

Komatsu, Yoshito ; Muro, Kei ; Chosa, Masayuki...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

14

Cardiovascular safety of pimitespib in patients with advanc..:

Naoki, Katsuhiko ; Igawa, Satoshi ; Uojima, Haruki...
Cancer. , 2024

Link: https://doi.org/10.1002/..

15

Plain language summary of the FOENIX-CCA2 study: futibatini..:

Goyal, Lipika ; Meric-Bernstam, Funda ; Hollebecque, Antoine...
Future Oncology. , 2024

Link: https://doi.org/10.1080/..